11GA001 Controlled Trial of “Follow On” Rifaximin

1st December 2012

Body: RFPB

Amount: £111,568.00

People
Photo Name Bio
professor-robin-spiller Professor Robin Spiller Robin's main interest is in the pathophysiology of functional GI diseases, particularly focusing on the role of infection and inflammation and alterations in serotonin metabolism in the irritable bowel syndrome. He has twice edited the British Society of…